Skip to content

Hypnosis as a Treatment of Chronic Widespread Pain in General Practice. A Pilot Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00521807
Enrollment
18
Registered
2007-08-28
Start date
2001-03-31
Completion date
2005-05-31
Last updated
2008-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Widespread Pain

Keywords

Hypnosis,, Chronic widespread pain,, CWP,, General Practice

Brief summary

Objective: The study was performed to evaluate the effect of a standardized hypnosis treatment used in general practice for patients with chronic widespread pain (CWP). Design: A randomized control group-controlled study. Setting and subjects: 16 patients were randomized into a treatment group or a control group, each constituting eight patients. Seven patients in the treatment group completed the schedule. After the control period, five of the patients in the control group also received treatment, making a total of 12 patients having completed the treatment sessions. Intervention: The intervention group went through a standardized hypnosis treatment with ten consecutive therapeutic sessions once a week, each lasting for about 30 minutes, focusing on ego-strengthening, relaxation, releasing muscular tension and increasing self-efficacy. Main outcome measures: A questionnaire was developed in order to calibrate the symptoms before and after the 10 weeks period, and the results were interpolated into a scale from 0 to 100, increasing numbers representing increasing suffering.

Interventions

PROCEDUREHypnosis

a standardized hypnosis treatment with ten consecutive therapeutic sessions once a week,

Sponsors

University of Oslo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Chronic widespread pain for at least three months and at most five years.

Exclusion criteria

* Patients having primarily other organic diseases or serious psychiatric disorders were excluded.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026